Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Gynecol Oncol. 2010 Mar 26;117(3):467–472. doi: 10.1016/j.ygyno.2010.02.008

Figure 3. Paired time to treatment failure comparison (2nd phase I trial vs. last conventional treatment).

Figure 3

Paired time-to-treatment failure as plotted by Kaplan-Meier for second phase I therapy compared to the last conventional treatment before referral to the phase I clinic. Tic marks represent patients still on treatment and therefore censored at the time shown. There was a trend, albeit not statistically significant, towards a longer time-to-treatment failure for patients' second phase I trial as compared to their last conventional treatment.